Announced Thu, 23 Jul · 12:24 IST
Board meeting on July 29 to approve Q1 FY27 results
Results View source PDF
ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.1%1-day move
₹1440.90
prior close
₹1417.60
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.0-0.0-0.0-0.0-3.1-1.9————————
Up moveDown movePending
AI summary
Eris Lifesciences has informed exchanges that its Board will meet on July 29, 2026 to consider and approve standalone and consolidated unaudited financial results for Q1 FY27 (quarter ended June 30, 2026). The trading window for insiders is already closed from July 1, 2026 and will reopen 48 hours after the results are declared, as per SEBI insider trading rules.
Likely market impact
Q1 FY27 results expected on July 29. Watch revenue, margins, and profit versus year-ago quarter and street expectations.